Pfizer, Myovant begin dosing in relugolix contraceptive study by Lucy Parsons | Apr 14, 2021 | News | 0 Dosing has begun in a Phase III study evaluating the contraceptive efficacy of relugolix combination tablet Read More
UK launch for Bayer’s five-year contraceptive Kyleena by Selina McKee | Feb 9, 2018 | News | 0 A new long-acting reversible contraception method offering protection from unplanned pregnancy for up to five years has been launched in the UK. Read More
Bayer bags EU nod for 5yr contraceptive by Selina McKee | Oct 5, 2016 | News | 0 Bayer has been given a green light in the EU for its low-dose levonorgestrel-releasing intrauterine system as a means to prevent pregnancy. Read More